The authors describe the use of gabapentin in the treatment of 4 outpatients with dementia-associated agitation. On the basis of clinical case reports and the Overt Agitation Severity Scale, all 4 patients had reduced agitation with gabapentin. Three of 4 patients were successfully titrated to a full dose of 2,400 mg/day. These findings suggest a possible role for gabapentin in the behavioral management of patients with dementia.
|Number of pages
|Journal of Neuropsychiatry and Clinical Neurosciences
|Published - 2000